看看查看全文
来源:格隆汇 格隆汇6月14日丨Agile Therapeutics(AGRX.US)盘前涨35.65%,报4.87美元。Agile Therapeutics宣布与VitaCare处方服务公司达成新协议,以扩大Twirla的使用范围,推动公司2023年实现净收入2500万至30... 网页链接
$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-21-126012 Size: 6 KB 网页链接
$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-21-126014 Size: 7 KB 网页链接
$Agile Therapeutics(AGRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-21-124717 Act: 33 Size: 596 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K Current report, items 5.02, 7.01, 8.01, and 9.01 Accession Number: 0001104659-21-124720 Act: 34 Size: 630 KB 网页链接
$Agile Therapeutics(AGRX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-21-124697 Size: 9 KB 网页链接
$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-21-124699 Size: 7 KB 网页链接
$Agile Therapeutics(AGRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-21-124246 Act: 33 Size: 596 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001558370-21-012978 Act: 34 Size: 229 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001558370-21-012390 Act: 34 Size: 3 MB 网页链接
$Agile Therapeutics(AGRX)$ 8-K Current report, items 1.01 and 2.03 Accession Number: 0001558370-21-010826 Act: 34 Size: 154 KB 网页链接